Total Funding
31
39
Total FundingVenture - Series Unknown raised
Growth Score 31 in past quarter
-4 pts
Heat Score 39 in past quarter
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
207686
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer.
Lorraine Thelian: Sr. Consultant Health TechnologyPast Role: Ketchum, Sr. Partner North America- Jerry Parrott: President & CEO
About the Company
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer. BioMarker Strategies is a tissue-based cancer diagnostics company.
It was founded in 2006 and is headquartered in Baltimore, Maryland.
